Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults (clinicaltrials.gov) - Feb 24, 2025 - P1 | N=160 | Not yet recruiting | Sponsor: Clover Biopharmaceuticals USA, LLC
New P1 trial • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections
|